About Us

A century ago, CSL made a promise to protect the health of a nation and help save and improve the lives of people with serious diseases. Today, this same promise is stronger than ever. Over the last 100 years, CSL has grown into a global biotechnology leader delivering innovative therapies to patients all around the world. With a unique combination of R&D focus, operational excellence and commercial strength, CSL is well-positioned to continue its leadership into the second century.

CSL at a glance:

• 35+ countries of operations around the world
• US$9.1+ Billion in annual revenue
• 8 Manufacturing sites – Australia (2), China, Germany, Switzerland, United Kingdom, United States (2)
• 27+ thousand employees around the world
• US$3.7 Billion in R&D investments in the last 5 years
• 1,700+ R&D employees
• 270+ Plasma collection centres across Europe and North America

We are driven by our passion and commitment to patients and stakeholders we serve around the world.